Discover what the measure aims to change, who it affects, and why it matters.
For full details and official documents, visit the Commission’s site
Reception Date
17.05.24
Category
PHARMACEUTICAL AND COSMETICS
PHARMACEUTICAL AND COSMETICS
Ministries & Departments
Agence fédérale des médicaments et produits de santé
Responsible Departments
SPF Economie, PME, Classes moyennes et Energie
Products & Services concerned
the supply of the products indicated in the Decree of the Regent – (pseudo)ephedrine and fusidic acid – subject to prescription
Related EU Law
None
The aim is to make the supply of the products indicated in the Decree of the Regent subject to prescription, for several reasons.
An amendment to the Decree of the Regent of 6 February 1946 regulating the storage and sale of poisonous and toxic substances in order to change the status of ephedrine- and pseudoephedrine-based substances from ‘free supply: TF’ or ‘upon written request: TD’ to ‘with a medical prescription’.
This timeline summarizes key events in the notification process
Track the evolution of this law — uncover the changes made from draft to final version based on input from the Commission, key organisations, and Member States.
This might mean the notification is still being reviewed,
or the final legislation hasn’t been uploaded to the system.
| Organisation | Comments | Date | Total Contributions |
|---|---|---|---|
| BAPIE | 2024-07-17 | 1 | |
| nonprofit organisation (VZW / ASBL) | Download | 2024-07-16 | 1 |
Commenting Organisation
Network
Notified law